Disease/Infection News

RSS

Media examine GHI, U.S. HIV/AIDS funding

PBS' NewsHour's "The Rundown" blog examines the recent naming of eight countries to receive additional technical and management resources under President Barack Obama's Global Health Initiative (GHI).

23 Jun 2010

AIDS specialist leaves Calif. practice, citing rising costs

A long-time San Francisco AIDS specialist is closing his clinic and moving to Manhattan because of frustration with the insurance industry and the rising cost of practicing medicine, the San Francisco Chronicle reports. "The bottom line is, you cannot make a living practicing medicine unless you work at least 50 to 60 hours a week," said Dr. Marcus Conant, one of the first AIDS doctors in the area. "I'm not the only doctor who's getting to the point where it's not worth it."

23 Jun 2010

Scientists complete comparative analysis of bacterial communities living in human nose, throat

Scientists have completed the most comprehensive comparative analysis to date of bacterial communities inhabiting the human nose and throat, which could provide new insights into why some individuals become colonized with pathogens while others do not. They release their findings today in mBio- the online open-access journal published by the American Society for Microbiology.

22 Jun 2010

Beneficial effects of LifeVantage's Protandim on DMD mouse model published in Journal of Dietary Supplements

LifeVantage Corporation, the maker of Protandim®, a patented, science-based solution to oxidative stress, announced today that a peer-reviewed manuscript was published in the Journal of Dietary Supplements examining the beneficial effects of Protandim® on a mouse model of Duchenne Muscular Dystrophy (DMD), an X-linked inherited disease affecting one in 3,500 males.

22 Jun 2010

NIH, Wellcome Trust partner to support population-based genetic studies of disorders, communicable diseases in Africa

The National Institutes of Health, an agency of the U.S. Department of Health and Human Services, and the Wellcome Trust, a global charity based in London, today announced a partnership to support population-based genetic studies in Africa of common, non-communicable disorders such as heart disease and cancer, as well as communicable diseases such as malaria.

22 Jun 2010

BD, PEPFAR commence multi-year initiative to improve blood collection practices in African clinics, hospitals

BD (Becton, Dickinson and Company), a leading global medical technology company, and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) today set in motion a joint, multi-year initiative to improve blood collection practices in African clinics and hospitals.

From BD (Becton, Dickinson and Company) 22 Jun 2010

Report says G8 countries short $10B on $50B commitment, reveals mixed progress on health goals

An accountability report, prepared by officials in G8 member countries' foreign affairs departments, acknowledges that G8 "countries are $10 billion behind the five-year, $50-billion commitment they made at their 2005 summit in Scotland," the Canadian Press/CTV News reports (6/20).

22 Jun 2010

Protesters ask U.S. to boost funding for Global Fund, HIV/AIDS programs in Africa

Thousands of protesters in Pretoria, South Africa, Thursday "demand[ed] the U.S. increase its AIDS funding for Africa," the Associated Press reports (Naki, 6/17). The protesters delivered a letter to the consulate saying the U.S. is "cutting funding to the Global Fund to Fight AIDS, Tuberculosis and Malaria," which health advocates believe could lead "other countries to follow suit and reduce funding for the fight against HIV," Agence France-Presse writes (6/17).

22 Jun 2010

FDA approves ARCHITECT HIV Ag/Ab Combo assay to aid in diagnosis of HIV-1/HIV-2 infection

The U.S. Food and Drug Administration today approved the first assay to detect both antigen and antibodies to Human Immunodeficiency Virus. This assay is approved for use as an aid in the diagnosis of HIV-1/HIV-2 infection in adults including pregnant women. It is also the first assay for use as an aid in the diagnosis of HIV-1/HIV-2 infection in children as young as two years old.

22 Jun 2010

Also in Global Health News: WHO scraps drug development group; Access to medication in Philippines; Yellow fever vaccine shortage; HIV-positive employee protection

Lancet World Report examines how "[d]isappointment over a long-awaited report on improving drug research and development for neglected diseases" led the WHO to form a new Consultative Expert Working Group (CEWG) to strategize around drug research and development. The formation of the new group comes after the report from the previous working group (EWG) was questioned due to "what some perceived to be a missed opportunity, unclear methods, a lack of transparency and signs of industry interference" and after "suspicions of impropriety" surfaced.

21 Jun 2010

FDA approves Abbott's ARCHITECT HIV Ag/Ab Combo assay

Every nine and a half minutes, someone in the United States is infected with HIV, and one out of every five of these individuals doesn't know it. To help stem the spread of this disease, the U.S. Food and Drug Administration (FDA) today approved an innovative new diagnostic tool, which will allow patients to be diagnosed earlier than ever before.

21 Jun 2010

MDT aligned with AAP position statement on efforts to be made to save patient's natural dentition

Millennium Dental Technologies, Inc. (MDT), pioneers of the patented LANAP™ protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser, are aligned with the American Academy of Periodontology (AAP) position statement that "efforts should be made to save a patient's natural dentition."

21 Jun 2010

Antibacterial lab coats to help prevent spread of disease in hospitals

According to the Centers for Disease Control and Prevention, 99,000 people die every year from infections acquired while in hospitals. "The goal in our profession is to help cure you not introduce you to another deadly infection," said Dr. Charles Kinder, Heart Rhythm expert and Director of Heart Rhythm Program at Heart Care Centers of Illinois.

21 Jun 2010

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant protection in the initial animal survival studies of Dengue virus infection. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley.

21 Jun 2010

AHF's Magic Johnson Testing America Tour arrives in Burlington to offer free HIV testing

AHF's Magic Johnson 'Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Burlington, Vermont today and will offer free HIV testing, along with local partner Vermont Cares from 11:00 AM to 3:00 PM at the corner of Church St. and Main St. The testing will take place on AIDS Healthcare Foundation's new, state-of-the-art 'Testing America' mobile HIV testing unit named in honor of and in partnership with basketball legend Earvin "Magic" Johnson, Jr., as well as on the North Jersey AIDS Alliance mobile testing unit.

21 Jun 2010

Study examines ability of organisms to survive, sustain against various infectious diseases

"Robust" is an adjective appreciatively applied to certain vintage wines, but when describing viruses and pathogens, robustness is a property that may be much less desirable. It evokes drug resistant microbes and other superbugs that can wreak havoc as researchers struggle to deal with new pandemics. How can we undercut this robustness?

21 Jun 2010

Fastest growing waste in the EU could help combat hospital infections: Scientists

The fastest growing waste in the EU could soon be helping to combat hospital infections, according to scientists at the University of York.

19 Jun 2010

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

NexBio, Inc. announced today the publication of a "Major Article" in the Journal of Infectious Diseases of a preclinical study showing that treatment with DAS181 (Fludase) inhibits infection with multiple human parainfluenza virus strains. DAS181 is a broad spectrum host-targeted investigational drug candidate for treatment and prevention of Influenza-Like Illness.

19 Jun 2010

Drug-resistant malaria spreading beyond Western Cambodia, U.S. malaria coordinator says

Resistance to artemisinin-based malaria medications seems to be spreading beyond western Cambodia, where it was first detected, U.S. global malaria coordinator Timothy Ziemer said during a visit to the region this week for a conference, Agence France-Presse reports.

19 Jun 2010

Brazil's deforestation linked to increased malaria incidence, study says

Deforestation in Brazil has been linked to an increase in malaria incidence there, according to findings published online Wednesday in the CDC journal, Emerging Infectious Diseases, Agence France-Presse reports.

19 Jun 2010

Disease/Infection News

Media examine GHI, U.S. HIV/AIDS funding

AIDS specialist leaves Calif. practice, citing rising costs

Scientists complete comparative analysis of bacterial communities living in human nose, throat

Beneficial effects of LifeVantage's Protandim on DMD mouse model published in Journal of Dietary Supplements

NIH, Wellcome Trust partner to support population-based genetic studies of disorders, communicable diseases in Africa

BD, PEPFAR commence multi-year initiative to improve blood collection practices in African clinics, hospitals

Report says G8 countries short $10B on $50B commitment, reveals mixed progress on health goals

Protesters ask U.S. to boost funding for Global Fund, HIV/AIDS programs in Africa

FDA approves ARCHITECT HIV Ag/Ab Combo assay to aid in diagnosis of HIV-1/HIV-2 infection

Also in Global Health News: WHO scraps drug development group; Access to medication in Philippines; Yellow fever vaccine shortage; HIV-positive employee protection

FDA approves Abbott's ARCHITECT HIV Ag/Ab Combo assay

MDT aligned with AAP position statement on efforts to be made to save patient's natural dentition

Antibacterial lab coats to help prevent spread of disease in hospitals

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

AHF's Magic Johnson Testing America Tour arrives in Burlington to offer free HIV testing

Study examines ability of organisms to survive, sustain against various infectious diseases

Fastest growing waste in the EU could help combat hospital infections: Scientists

Preclinical study shows treatment with DAS181 inhibits infection with multiple HPIV strains

Drug-resistant malaria spreading beyond Western Cambodia, U.S. malaria coordinator says

Brazil's deforestation linked to increased malaria incidence, study says

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News